Previous 10 | Next 10 |
Gainers: Aclaris Therapeutics (NASDAQ: ACRS ) +68% . Avadel Pharmaceuticals plc (NASDAQ: AVDL ) +20% . BioCardia ( OTCQB:BCDA ) +15% . Lexicon Pharmaceuticals (NASDAQ: LXRX ) +14% . Earthstone Energy (NYSE: ESTE ) +14% . Pier 1 Imports (NYSE: PIR ) +15% . SunPower Corporation (...
Thinly traded nano cap Leap Therapeutics (NASDAQ: LPTX ) is up 5% premarket on light volume in response to updated data from its ongoing Phase 2 clinical trial evaluating lead candidate DKN-01, as monotherapy and in combination with chemo agent paclitaxel, in patients with adva...
CAMBRIDGE, Mass. , Sept. 17, 2019 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX) today announced an oral and poster presentation of updated clinical data from its ongoing Phase 2 clinical trial of DKN-01, its anti-Dickkopf-1 (DKK1) antibody, as both a monotherapy and in c...
CAMBRIDGE, Mass. , Sept. 4, 2019 /PRNewswire/ -- Leap Therapeutics, Inc. (NASDAQ: LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, today announced that Christopher K. Mirabelli , Ph.D., Chairman, President and Chief Executive Officer, will present...
Leap Therapeutics (NASDAQ: LPTX ): Q2 GAAP EPS of -$0.37 beats by $0.05 . More news on: Leap Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
CAMBRIDGE, Mass. , Aug. 9, 2019 /PRNewswire/ -- Leap Therapeutics, Inc. (NASDAQ: LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, today reported financial results for the second quarter ended June 30, 2019 . "We recently presented positive data ...
Dean Foods (NYSE: DF ) -31% on Q2 earnings . More news on: Dean Foods Company, GreenSky, Inc., Leap Therapeutics, Inc., Stocks on the move, Read more ...
CAMBRIDGE, Mass. , July 25, 2019 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that it will host a conference call on August 6, 2019 , to provide a program update for DK...
Vislink Technologies (NASDAQ: VISL ) -31% on filing to offer 7.27M shares. More news on: Vislink Technologies, Inc., Camber Energy, Inc., Leap Therapeutics, Inc., Stocks on the move, Read more ...
Thinly traded nano cap Leap Therapeutics (NASDAQ: LPTX ) slips 10% premarket on average volume in reaction to stock purchase agreements with Lincoln Park Capital Fund, LLC. More news on: Leap Therapeutics, Inc., Healthcare stocks news, Stocks on the move, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Leap Therapeutics Inc. Company Name:
LPTX Stock Symbol:
NASDAQ Market:
Leap Therapeutics Inc. Website:
Leap Therapeutics Reports First Quarter 2024 Financial Results PR Newswire CAMBRIDGE, Mass. , May 13, 2024 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today report...
Leap Therapeutics Announces $40 Million Private Placement PR Newswire Net proceeds, along with existing cash, cash equivalents, and marketable securities are expected to extend cash runway into Q2 2026 and enable expansion of DKN-01 DeFianCe clinical trial and development prog...
Leap Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results PR Newswire CAMBRIDGE, Mass. , March 18, 2024 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeut...